UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

Under the Securities Exchange Act of 1934
(Amendment No. )

Endra Life Sciences Inc.
(Name of Issuer)

COMMON STOCK
(Title of Class of Securities)

29273B104
(CUSIP Number)

SEC 1745 (3-98) Page 1 of 7


October 31, 2018 13G Page 2 of 7 Pages
(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

/_X__/ Rule 13d-1(b) /____/ Rule 13d-1(c) /____/ Rule 13d-1(d)

* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.


CUSIP No. 29273B104             13G             Page 3 of 7 Pages
----------------------------------------------------------------
1       NAME OF REPORTING PERSONS
        IRS IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)

        ICM Asset Management, Inc.                     91-1150802
----------------------------------------------------------------
2       CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
        (a)/ X /
        (b)/  /
----------------------------------------------------------------
3       SEC USE ONLY

----------------------------------------------------------------
4       CITIZENSHIP OR PLACE OF ORGANIZATION

        Washington
----------------------------------------------------------------
          NUMBER OF     5 SOLE VOTING POWER
           SHARES         0
        BENEFICIALLY  ---------------------------------------
          OWNED BY      6 SHARED VOTING POWER
            EACH          561,426
         REPORTING        ---------------------------------------
           PERSON       7 SOLE DISPOSITIVE POWER
            WITH          0
                          ---------------------------------------
                        8 SHARED DISPOSITIVE POWER
                          561,426
------------------------------------------------------------------
9       AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING
                PERSON
        561,426
----------------------------------------------------------------
10      CHECK IF THE AGGREGATE AMOUNT IN ROW (9)
                EXCLUDES CERTAIN SHARES*
        0
----------------------------------------------------------------
11      PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW 9
        10.4%
----------------------------------------------------------------
12      TYPE OF REPORTING PERSON (See Instructions)
        IA
----------------------------------------------------------------


CUSIP No. 29273B104     13G                     Page 4 of 7 Pages

ITEM 1.

     (a)  The name of the issuer is Endra Life Sciences Inc.
            (the "Issuer").

     (b)  The principal executive office of the Issuer is located at:
           3600 Green Court, Suite 350
           Ann Arbor, MI 48105-1570

ITEM 2.

     (a)  The names of the persons filing this statement are:
          ICM Asset Management, Inc.
          (collectively, the "Filers").

     (b)  The principal business office of the Filers is located at:
          601 W. Main Avenue, Suite 900
          Spokane, WA  99201.

     (c)  See Item 4 of the cover sheet for each Filer.

     (d)  This statement relates to shares of common stock of the Issuer
          (the "Stock").

     (e)  The CUSIP number of the Stock is 29273B104.


CUSIP No. 29273B104                     13G             Page 5 of 7 Pages

ITEM 3.  If this statement is filed pursuant to rule 240.13d-1(b)
or 240.13d-2(b) or (c), check whether the person filing is a:

        (a)     ___     Broker or dealer registered under section 15 of the Act
                                        (15 U.S.C. 78o).

        (b)     ___     Bank as defined in section 3(a)(6) of the Act (15 U.S.C.
                                        78c).

        (c)     ___     Insurance company as defined in section 3(a)(19) of the
                                        Act (15 U.S.C. 78c).

        (d)     ___     Investment company registered under section 8 of the
                                        Investment Company Act of 1940 (15 U.S.C. 80a-8).

        (e)     _X__    An investment adviser in accordance with 240.13d-
                                        1(b)(1)(ii)(E) (as to ICM Asset Management, Inc.).

        (f)     ___     An employee benefit plan or endowment fund in accordance
                                        with 240.13d-1(b)(1)(ii)(F).

        (g)     ___     A parent holding company or control person in accordance
                                        with 240.13d-1(b)(1)(ii)(G) (as to James M. Simmons).

        (h)     ___     A savings association as defined in section 3(b) of the
                                        Federal Deposit Insurance Act (12 U.S.C. 1813).

        (i)     ___     A church plan that is excluded from the definition of an
                                        investment company under section 3(c)(14) of the
                                        Investment Company Act of 1940 (15 U.S.C. 80a-3).

        (j)     ___     Group, in accordance with section 240.13d-1(b)(1)(ii)(J)
                        (as to ICM Asset Management, Inc. and James M. Simmons).


CUSIP No.  29273B104                    13G             Page 6 of 7 Pages

ITEM 4.  OWNERSHIP

See Items 5-9 and 11 on the cover page for each Filer.


ITEM 5.  OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS

If this statement is being filed to report the fact that as of the date
hereof the reporting person has ceased to be the beneficial owner of more
than five percent of the class of securities, check the following /___/.


ITEM 6.  OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF ANOTHER PERSON

ICM Asset Management, Inc. is a registered investment adviser whose
clients, have the right to receive or the power to direct the receipt
of dividends from, or the proceeds from the sale of, the stock.
James M. Simmons is the Chief Executive Officer and controlling shareholder
of ICM Asset Management, Inc. No individual client's holdings of the stock
are more than five percent of the outstanding stock.


CUSIP No. 29273B104                     13G             Page 7 of 7 Pages


ITEM 7.  IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH ACQUIRED
THE SECURITY BEING REPORTED ON BY THE PARENT HOLDING COMPANY

Not applicable.

ITEM 8.  IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE GROUP

ICM Asset Management, Inc., and James M. Simmons constitute a group
within the meaning of rule 13d-5(b)(1), but are not part of a group with
any other person.

ITEM 9.  NOTICE OF DISSOLUTION OF GROUP

Not applicable.

ITEM 10.  CERTIFICATION

By ICM Asset Management, Inc.:

By signing below I certify that, to the best of my knowledge and belief,
the securities referred to above are held in the ordinary course of
business and were not acquired and are not held for the purpose of or
with the effect of changing or influencing the control of the
issuer of the securities and were not acquired and are not held in
connection with or as a participant in any transaction having that purpose
or effect.
                                SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true, complete
and correct.

Dated:  November 07, 2018

ICM Asset Management, Inc.



______________________________________
By:  James M. Simmons -  CEO

ENDRA Life Sciences (NASDAQ:NDRA)
Historical Stock Chart
From Apr 2024 to May 2024 Click Here for more ENDRA Life Sciences Charts.
ENDRA Life Sciences (NASDAQ:NDRA)
Historical Stock Chart
From May 2023 to May 2024 Click Here for more ENDRA Life Sciences Charts.